Headlands Technologies’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$55.5K	Buy	+49,556	New	+$55.5K	0.01%	756
2024 Q3	–	Sell	-28,508	Closed	-$93.5K	–	1294
2024 Q2	$93.5K	Buy	28,508 +27,976	+5,259%	+$91.8K	0.01%	659
2024 Q1	$3.91K	Buy	+532	New	+$3.91K	﹤0.01%	1121